Some patients arrive with a line and expect it gone. Not softened — gone. When it is still faintly visible at two weeks they conclude the treatment underperformed, and the conversation that follows is usually about dose when it should have been about mechanism.
“Botox Is Not an Eraser”
Maritza Mejia FNP has a name for the patients this affects most.
“I used to call them line chasers,” she says. “They used to chase every single line. And I say, Botox is not an eraser. It's just a relaxed movement.”
That sentence does more work than any explanation of receptor physiology. Neurotoxin reduces muscular contraction. Where a line is produced by movement, reducing the movement softens the line. Where a line has been etched into the skin over years, the movement is no longer what is holding it there.
The patient hearing “it relaxes movement” rather than “it removes lines” has been given a mechanism they can use to predict their own result — which is what prevents the disappointment at week two.
What Has Changed About the Request
The encouraging part is that this conversation is getting easier.
Mejia contrasts the old request with the current one: “Now they're coming and asking for a little movement with the glowing skin.” Patients increasingly do not want the frozen result at all — the shift described in why patients ask for half a syringe.
So the line chaser is now less common than the patient asking for restraint. But the underlying misconception survives in a new form: patients who expect a single treatment to resolve texture, tone and etched lines because they have heard those are treatable.
The Part Toxin Cannot Reach
When a line persists at rest, the remaining component is in the skin itself, and it needs a different tool.
Mejia's answer is to treat the surface directly: “That's why we also recommend to do microneedling, take care of the skin, do the exosomes, do the PDRN — just select the right treatment.”
This is the sequencing argument covered in skin first, biostimulator second, filler last, and the etched-line problem specifically in when toxin will not fix a static line.
The consultation version is simple: separate the line that appears when you move from the line that is there when you do not. The first is a toxin conversation. The second is a skin conversation. Most faces need both, and saying so at the start converts a future complaint into a treatment plan.
The Other Half: It Is Not One and Done
Mejia identifies the second misconception as more damaging than the first.
Ready to put this into practice?
Explore Empire's hands-on, CME-accredited Aesthetic & Injectable Training courses — live patients, expert faculty, and ongoing mentorship.
“Anytime that we do any of those treatments, I always say it's not just one time, because that's the misconception with a lot of these treatments,” she says. “People think they're going to do it once and it's going to be that's it.”
Her analogy is the one every patient understands: “It's like when you sign into a gym. It doesn't mean you're going to get a six pack the first time. You have to keep working out until you get it. So you have to trust the process.”
And the part patients like least: “What you do at home after you leave the office. So we send everybody with the skincare products, because you have to also do your part. You have to do your homework — not just expecting me to fix it.”
Her sharper version of the same idea is that treating without homecare is like having a dental cleaning and then not brushing.
Why This Is a Retention Conversation
It is tempting to read all this as expectation management. It is also how the commercially strongest practices are built.
Melissa Pulcini-Buttine PA describes exactly that effect: “People used to come in and just want one syringe of filler, and then they may leave. Now we have them for years, because they're working with us on skin quality and all the different treatments. So we're retaining patients even longer, because it's a whole process. We're educating them.”
The patient told that one treatment will erase a line either gets a result that matches, and leaves, or does not, and leaves unhappy. The patient told this is a process that combines movement, surface and time stays — and is more satisfied, because the outcome they were promised is the one they get.
A Script That Works
- Demonstrate the distinction. Have them animate, then relax. Show them which lines move and which stay.
- Name the mechanism. “This relaxes movement. It is not an eraser.”
- Assign each finding to a tool. Movement lines to toxin, etched lines and texture to skin work.
- State the timeline out loud, including how many sessions and over what period.
- Give homecare a job, not a recommendation.
- Photograph at baseline. Patients cannot perceive gradual change without it.
Empire teaches this assessment in Complete Botox Training and the skin layer in Complete Facial Aesthetic Training.
Frequently Asked Questions
Why is a line still visible after Botox?
Because neurotoxin reduces muscular contraction rather than removing lines. A line produced by movement softens; a line etched into the skin over years is no longer held there by movement and needs skin-directed treatment instead.
What is a line chaser?
A patient who focuses on individual lines and expects each to be eliminated. Faculty reframe the mechanism — neurotoxin relaxes movement rather than erasing — so the patient can predict their own result.
Is one treatment enough?
Rarely. Faculty describe skin-directed treatments in particular as a course rather than a single event, and compare it to a gym membership — including the patient's own homecare between appointments.
What treats an etched line that Botox does not?
Skin-directed work — microneedling and regenerative options such as PDRN or exosomes, alongside appropriate skincare. The usual approach treats movement and surface as two separate components of the same complaint.
Disclaimer
This article is educational and intended for licensed clinicians. It is not medical advice and does not establish a clinician-patient relationship. Treatment planning and product selection are individual clinical decisions made by a qualified clinician who has examined the patient.


